| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to medicine, particularly to pharmaceutical treatment of atherosclerosis and an associated risk of cardiovascular diseases. That is ensured by using the effective amount of a Syk-kinase inhibitor representing N4-(2,2-dimethyl-4-[(dihydrophosphonoxy)methyl]-3-oxo-5-pyrido[1,4]oxazin-6-yl)-5-fluor-K2-(3,4,5-trimethoxyphenyl)-2,4-diamonopyrimidines and a salt thereof.EFFECT: method provides the substantial size reduction of the atherosclerotic involvements, particularly of the aortic root and arch.5 ex, 2 tbl, 2 dwg |
